UBS Group’s iTeos Therapeutics ITOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $442K | Buy |
|
|||||
|
2025
Q1 | $157K | Sell |
|
|||||
|
2024
Q4 | $715K | Buy |
|
|||||
|
2024
Q3 | $447K | Buy |
|
|||||
|
2024
Q2 | $436K | Sell |
|
|||||
|
2024
Q1 | $806K | Buy |
|
|||||
|
2023
Q4 | $496K | Buy |
|
|||||
|
2023
Q3 | $253K | Sell |
|
|||||
|
2023
Q2 | $592K | Buy |
|
|||||
|
2023
Q1 | $594K | Sell |
|
|||||
|
2022
Q4 | $1.77M | Buy |
|
|||||
|
2022
Q3 | $1.29M | Sell |
|
|||||
|
2022
Q2 | $3.26M | Sell |
|
|||||
|
2022
Q1 | $5.49M | Buy |
|
|||||
|
2021
Q4 | $1.76M | Buy |
|
|||||
|
2021
Q3 | $4K | Sell |
|
|||||
|
2021
Q2 | $74K | Sell |
|
|||||
|
2021
Q1 | $428K | Buy |
|
|||||
|
2020
Q4 | $122K | Buy |
|